Nusinersen and risdiplam for treating spinal muscular atrophy (review of TA588 and TA755) [ID6195]
In development
Reference number: GID-TA11386
Expected publication date: TBC
Following the committee meeting on 3rd February 2026, NICE is working with the companies and NHS England to finalise the recommendations. The committee doesn’t need any further information or analysis, and we don’t anticipate any further committee meetings will be required. We anticipate being able to update stakeholders by w/c 9 March 2026.